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Abstract 
Background: The unilaterally-lesioned 6-hydroxydopamine (6-OHDA) rat is one of the most 
commonly used experimental models of Parkinson’s disease (PD). Here we investigated 
whether magnetic resonance imaging (MRI) that is widely used in human PD research, has 
the potential to non-invasively detect macroscopic structural brain changes in the 6-OHDA 
rat in ways translatable to humans. 
Methods: We measured the grey matter composition in the unilateral 6-OHDA rat in 
comparison to sham animals using whole-brain voxel-based morphometry (VBM) - an 
unbiased MR image analysis technique. The number of nigral dopamine neurons and the 
density of their cortical projections were examined post-mortem using 
immunohistochemistry.  
Results: VBM revealed widespread bilateral changes in grey matter volume on a topographic 
scale in the brains of 6-OHDA rats, compared to sham-operated rats. The greatest changes 
were in the lesioned hemisphere, which displayed reductions of grey matter volume in 
motor, cingulate and somatosensory cortex. Histopathological results revealed dopaminergic 
cell loss in the substantia nigra and a denervation in the striatum, as well as in the frontal, 
somatosensory and cingulate cortices. 
Conclusion: Unilateral nigrostriatal 6-OHDA lesioning leads to widespread grey matter volume 
changes, which extend beyond the nigrostriatal system and resemble advanced 
Parkinsonism. This study highlights the potential of structural MRI, and VBM in particular, for 
the system-level phenotyping of rodent models of Parkinsonism and provides a 
methodological framework for future studies in novel rodent models as they become 
available to the research community. 
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Abbreviations 
6-OHDA, 6-hydroxydopamine; ANOVA, analysis of variance; CSF, cerebrospinal fluid; DA, 
dopamine; DAB, diaminobenzidine; DARTEL, diffeomorphic anatomical registration using 
exponentiated lie algebra; FWER, family-wise error rate; GM, grey matter; GMV, grey matter 
volume; MFB, medial forebrain bundle; MRI, magnetic resonance imaging; PD, Parkinson's 
disease; PST, population-specific template; ROI, region(s) of interest; SEM, standard error of 
the mean; T2W, T2-weighted; TBS, Tris-buffered saline; TH, tyrosine hydroxylase; TH+, 
tyrosine hydroxylase positive; VBM, voxel-based morphometry; WM, white matter; WMV, 
white matter volume 
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Introduction 
Parkinson’s disease (PD) is a multi-system, progressive neurodegenerative movement 
disorder (Lees et al., 2009). Pathological hallmarks of the disease include degeneration of 
dopamine (DA) neurons in the substantia nigra (SN) pars compacta and the presence of 
alpha-synuclein immunopositive Lewy bodies in the surviving DA neurons (Spillantini et al., 
1997, Lees et al., 2009). Currently there are no treatments that can slow, halt or reverse the 
progressive neurodegeneration that occurs in PD (Stocchi and Olanow, 2013). Addressing this 
unmet medical need requires the generation of animal models that show improved 
construct, face and predictive validity to the human disorder (see (Duty and Jenner, 2011) for 
review)). The development of reliable and validated cross-species biomarkers for the non-
invasive detection and longitudinal monitoring of neuropathological changes in rodent 
models, in a clinically comparable manner, would facilitate this process. For example, such 
markers would have the potential to be proxy measures of the efficacy of novel therapeutic 
interventions, particularly those with disease modifying potential. Magnetic resonance 
imaging (MRI) is well suited to this task. It is widely available, relatively inexpensive and 
mostly non-invasive, with excellent soft-tissue contrast and spatial resolution, permitting the 
detailed macro- and microscopic measurements of dynamic structural and functional 
parameters in both human and animal subjects (Finlay et al., 2014). In this context, there is 
an extensive literature on the use of structural MRI and computational image processing 
methods, particularly voxel-based morphometry (VBM) (Burton et al., 2004, Nagano-Saito et 
al., 2005, Summerfield et al., 2005, Song et al., 2011, Weintraub et al., 2011, Hattori et al., 
2012, Menke et al., 2013) to map the spatiotemporal sequence of topographical brain 
changes in Parkinsonism and related disorders. Overall, these data show that cortical atrophy 
in prefrontal, temporal, occipital and parietal cortices can be generally observed even in early 
stage PD, but is more pronounced in advanced PD, specifically in the temporal brain areas in 
PD patients with dementia.  
Despite this, MRI-based measures are yet to be adopted as primary outcomes in clinical trials 
in the assessment of novel therapeutics and the utility of structural MRI as a true biomarker 
for PD remains somewhat unclear. One obstacle is the inconsistency between structural 
imaging studies, which is likely caused by multiple factors such as differences in the number 
of subjects, duration of the disease, the heterogeneity of Parkinsonism and the use of 
different image analysis methods in different centres. In addition, human MRI studies cannot 
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(to date) identify the cellular mechanisms that drive structural brain changes (particularly 
grey matter volume (GMV) and white matter volume changes) including whether these are 
specific to defined populations of vulnerable neurons – in this case, the A9 DA neurons in the 
SN. Together, these represent a significant barrier to the use of routine anatomical MRI to 
track disease progression and neuroprotective efficacy of novel (or repurposed) drugs in PD 
patients. 
To address these issues, one fruitful approach may be to phenotype rodent models of 
Parkinsonism, in which genetic and environmental variables may be precisely controlled, with 
structural MRI (clinically-comparable technology) and computational image analysis tools 
relevant to human MR imaging to permit parallel processing. The unique advantage of this 
approach is that the spatiotemporal sequence of brain volume changes may be identified and 
then linked to post-mortem changes at the cellular and molecular level to identify potential 
underlying mechanisms that explain the same MR measurements in humans (Finlay et al., 
2014). Proof-of-concept for this approach is provided by prior studies in which longitudinal 
MRI was utilised to identify patterns of brain atrophy in rodents rendered hemi-parkinsonian 
following micro-injection of the proteasome inhibitor lactacystin into the nigrostriatal system 
(Vernon et al., 2010, Vernon et al., 2011, Harrison et al., 2015). Using deformation based 
morphometry these data replicated patterns of grey matter (GM) atrophy apparent in end-
stage PD patients with co-morbid dementia, including decreased volume of the putamen and 
widespread cortical regions, which did not appear to be driven by neuronal loss (Vernon et 
al., 2011). Interestingly, deformation based morphometry data also suggested GM atrophy of 
the ventral midbrain and thalamus, both of which were related to neuronal loss. Crucially 
however, whilst dopaminergic neurons may be preferentially sensitive to proteasome 
inhibition (McNaught et al., 2002) there is also evidence to suggest that synthetic 
proteasome inhibitors induce dose-dependent dopaminergic neuronal degeneration and are 
associated with a significant risk of non-specific neuronal and/or glial cell toxicity at higher 
doses (Vernon et al., 2010, Xie et al., 2010). Thus, whilst the MRI changes observed in these 
prior studies are clearly linked to DA depletion, the possibility that these may also reflect 
additional loss of other vulnerable neuronal or glial cell populations cannot be entirely 
excluded. Although this is not necessarily a limitation, since PD is clearly a multi-system 
disorder, it raises the question as to what the pattern of atrophy would be following specific 
and selective lesions of nigral dopaminergic neurons. Specifically, if brain structural changes 
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in such a model would be similar or different to both those found in the lactacystin rat and 
importantly, in clinical patients.  
We therefore sought to address this issue by providing a methodological framework for 
developing structural MRI biomarkers following a selective lesion of catecholaminergic 
neurons. Specifically, we collected structural MRI data from rodents lesioned with the 
catecholamine-neuron selective neurotoxin 6-hydroxydopamine (6-OHDA), the prototypical 
rat PD model (Ungerstedt, 1968). We analysed the MRI data using a recently-developed VBM 
procedure in rats that uses clinically relevant algorithms for the translational validation of 
pathoanatomical changes observed in humans (Suzuki et al., 2013). We also tested the 
hypothesis that the loss of DA neuron fibres may be a more prominent driver of extra-nigral 
atrophy in the cortex and striatum, since prior work in the lactacystin model found no change 
in neuronal number in these regions (Vernon et al., 2011). We therefore examined the 
pattern of tyrosine hydroxylase positive (TH+) fibre denervation post-mortem in the cortex of 
6-OHDA lesioned rats and sham controls. We hypothesised that the MRI phenotype of the 
classic 6-OHDA model resembles those seen in lactacystin-lesioned rats and in advanced 
clinical idiopathic Parkinson’s disease.  
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Experimental procedures 
 
Animals 
Adult male Sprague-Dawley rats (N=28; 260 ± 25g, Harlan, UK) were group-housed at 21±1°C 
in a 12 hour light:dark cycle and with ad libitum access to standard rat chow and drinking 
water. All experiments were conducted in accordance with the Home Office Animals 
(Scientific procedures) Act, UK, 1986 and were approved by the King’s College London ethical 
review committee.  
 
Unilateral 6-OHDA lesioning procedure 
Rats were divided into a sham-operated (N=12) or 6-OHDA lesioned group (N=16). Animals 
were anesthetized (isoflurane 2.5% in oxygen/air 1:4, 1 l/min, Baxter International Inc., 
Deerfield, IL, USA) and placed in a stereotaxic frame (Kopf Instruments, Tujunga, CA, USA). 
Stereotaxic intracerebral injections of 6-OHDA, or saline (control) were performed using a 
Hamilton syringe (Hamilton, Reno, NV, USA) and motorized syringe pump (Harvard 
Apparatus, Holliston, MA, USA). A severe lesion of the nigrostriatal pathway was obtained by 
injecting 12 μg 6-OHDA (Sigma-Aldrich, St. Louis, MO, USA) dissolved in 4 μl sterile saline 
(Sigma-Aldrich) containing 0.02% (w/v) ascorbic acid (Sigma-Aldrich) into the left medial 
forebrain bundle (MFB) at coordinates (mm) AP -4.4, ML 1 and -7.8 from dura, according to 
the rat stereotaxic atlas (Paxinos and Watson, 1997). Sham-operated animals underwent the 
same procedure but received 4 μl sterile saline only.  
 
Behavioural testing: Apomorphine-induced rotation test 
Two weeks post-surgery, the extent of the 6-OHDA lesioning was confirmed by the 
apomorphine-induced rotational test (Ungerstedt and Arbuthnott, 1970) as described 
previously (Vernon et al., 2011). Briefly, rats were placed in an automated rotameter and 
baseline activity recorded for 10 minutes. Rats then received a subcutaneous injection of 
apomorphine (0.1 mg/kg in 0.9% saline, E-Biomed GmbH, Heidelberg, Germany) and the 
number of ipsiversive and contraversive full body turns were recorded automatically over a 
period of 60 minutes. A cut-off of >100 net contraversive turns following apomorphine 
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challenge was utilised to confirm a significant lesion of nigral dopamine neurons (Papa et al., 
1994, Marin et al., 2007, Jang et al., 2012). Three 6-OHDA rats did not meet this rotation 
criteria following apomorphine challenge and were excluded from further analysis. Thus, 
N=13 6-OHDA-lesioned rats underwent MR imaging.  
 
Magnetic resonance imaging – Preparation and acquisition 
Structural MRI was performed three weeks (±2 days) post-surgery using a 7T MRI scanner 
(Agilent Technologies, Santa Clara, CA, USA) employing a custom-made birdcage quadrature 
radiofrequency head coil (72 mm diameter; Rapid Biomedical GmbH, Rimpar, Germany). This 
time point was chosen to avoid the well-described hyperintense areas on T2-weighted (T2W) 
images observed in 6-OHDA rats close to the injection site which persist until 14 days post-
lesioning (Dhawan et al., 1998, Kondoh et al., 2005). Animals were placed in the centre of the 
scanner, secured in a head frame and anaesthetized with isoflurane (~2% in 70/30 medical 
oxygen/air mixture delivered at 1 l/min) throughout the imaging procedure. Respiration, 
pulse and blood oxygenation were continuously monitored for the duration of the scan (SA 
instruments, Stony Brook, NY, USA). Body temperature was maintained at 37±1°C using a 
rectal probe and a thermostat-controlled air heating unit (SA instruments). Anatomical 
images were acquired using a 2D fast spin echo T2W pulse sequence with following 
parameters: 40 x 0.5 mm coronal slices, TEeff 60 ms, TR 4000 ms, flip angle 90°, averages 8, 
field of view 32 x 32 mm, matrix 128 x 256, giving an in-plane resolution of 0.25x0.125 mm, 
with a total acquisition time of 17 min. In the 6-OHDA group, three rats died after the image 
acquisition leaving N=13 6-OHDA rats for image analysis, and N=10 for histology. One sham 
rat was excluded from image analysis due to image artifacts leaving N=11 sham rats for 
image analysis, and N=12 for histology. 
 
Voxel-based morphometry  
To detect and analyse structural brain changes we applied VBM, an automated whole brain 
morphometry technique that allows automated evaluation of the grey matter composition of 
6-OHDA rats in comparison to shams. The VBM method described here follows the 
procedure described by Ashburner and Friston (Ashburner and Friston, 2000) with 
modifications for rat MRI datasets as reported previously (Suzuki et al., 2013). The T2W 
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images were processed and analysed using statistical parametric mapping software (SPM8, 
http://www.fil.ion.ucl.ac.uk/spm/, Wellcome Department of Cognitive Neurology, London, 
UK) and FMRIB Software Library (FSL v5.0; http://www.fmrib.ox.ac.uk, Analysis Group, 
FMRIB, Oxford, UK) and custom-written scripts in MATLAB (MathWorks Inc., Natick, MA, 
USA). Statistical parameter maps were visualized using MRIcroGL (v1.0; (Rorden and Brett, 
2000)). 
T2W anatomical images from each rat were first subjected to unified segmentation tool in 
SPM8 (Ashburner and Friston, 2005), which enables tissue classification, bias correction, 
segmentation and image registration into a reference stereotaxic space defined by a set of 
tissue probability templates (Figure 1) (Valdes-Hernandez et al., 2011). Following 
segmentation, the tissue class images of GM, white matter (WM) and cerebrospinal fluid 
(CSF) for each rat were used to create a population-specific template (PST) by running the 
diffeomorphic anatomical registration using exponentiated lie algebra (DARTEL) template-
creation tool in SPM8 (Ashburner, 2007). The segmented grey and white matter tissue class 
images were then spatially and nonlinearly normalized (warped) using the outputs from the 
previous DARTEL step and modulated by the Jacobian determinant at each voxel to obtain 
grey and white matter volume maps. The resulting grey and white matter volume maps were 
then spatially smoothed by convolving them with an isotropic Gaussian kernel of 0.1875 mm 
full-width at half maximum. This small smoothing kernel has been previously shown to be 
most effective for the subsequent non-parametric permutation tests (Smith and Nichols, 
2009).  
Finally, we selected the 30 brain regions with most significant changes by performing a region 
of interest (ROI)-based extraction of q-values on the resulting SPM map. The extraction was 
done using the MarsBaR toolbox (Brett et al., 2002) and 154 (77 in each hemisphere) 
digitized cortical and subcortical structures spanning most of the brain. Within each ROI the 
most significant voxel was determined and the 30 brain regions with the most significant 
voxels were reported. The ROIs were derived from the Gaser rat brain atlas (Gaser et al., 
2012), which is located in the space of the Paxinos atlas (Paxinos and Watson, 1997). To 
transfer the ROIs to our study rat brain template (Valdes-Hernandez et al., 2011), the Gaser 
rat brain atlas was nonlinearly normalized to it using SPM8’s normalization tool. Figure 2 
shows the rat brain parcellation scheme chosen for the ROI-based q-value extraction. After 
completion of the VBM analysis, the obtained SPM threshold maps (in the PST space) 
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containing significant voxels of GMV and white matter volume (WMV) changes were 
nonlinearly normalized to the rat brain template using nearest neighbour interpolation. This 
way, the threshold maps and the ROIs were located in the same spatial space.  
Note, the terms GM, WM and CSF refer to tissue classifications in the MR images. In 
particular, some subcortical parts of the brain including the thalamus, which are not strictly 
WM are classified as such due to their appearance in the MR images, an issue that has 
previously been raised for the priors used in this study (Valdes-Hernandez et al., 2011, Suzuki 
et al., 2013, Otte et al., 2015). Therefore, in this study, WM should be understood as tissues 
with MR contrast similar to WM such as white matter fibres or subcortical brain areas like the 
thalamus. The smoothed GM and WM compartments were added to constitute the final 
volume map for the statistical analysis. 
 
Figure 1 
Figure 2 
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Histological analysis 
 
Tissue collection 
Animals were sacrificed by transcardial perfusion using heparinised saline followed by 4% 
paraformaldehyde (Hitobiotec Corp, Kingsport, TN, USA) immediately after the completion of 
the MRI. Animals were decapitated and their brains quickly removed and immersed in 4% 
paraformaldehyde for two days, followed by cryoprotection in 30% sucrose (Sigma-Aldrich) 
for two days at 4C°. Brains were then sectioned at 30 μm on a freezing microtome (Leica, 
Wetzlar, Germany) at -20C°. Serial coronal sections were subsequently placed in 12-well 
plates (Thermo Fisher Scientific, Waltham, MA, USA) in 12 series and stored at -20°C until 
processed for immunohistochemistry.  
 
Immunohistochemistry 
Immunohistochemistry was conducted in ten 6-OHDA rats and 12 sham operated rats. 
Sections were stained with anti-tyrosine hydroxylase (TH) antibody to mark catecholamine 
neuron cell bodies and their axons. Free-floating sections were pre-treated for 15 min with 
1% H2O2 (Sigma-Aldrich), washed three times with Tris-buffered saline (TBS; Sigma-Aldrich), 
blocked with normal goat serum (1:10; Vector Laboratories, Burlingame, CA) and 0.1% Triton-
X 100 (Sigma-Aldrich) for 40 min, and then incubated overnight at 4°C with primary antibody 
(rabbit anti-TH, 1:3000, monoclonal; Chemicon, Temecula, CA, USA). The sections were then 
washed three times with TBS and incubated with biotinylated goat anti-rabbit (1:1000; 
Vector Laboratories) secondary antibody for 120 min at room temperature. After three rinses 
in TBS, the sections were incubated for one hour at room temperature with peroxidase-
conjugated avidin–biotin complex kit (Vector Laboratories), washed three times with TBS, 
and then incubated with 0.02% diaminobenzidine (DAB; Vector Laboratories) until staining 
was visible. The mounted sections were dehydrated using 100% methylated spirit (Thermo 
Fisher Scientific) and embedded in DePeX mounting medium (Serva, Heidelberg, Germany). 
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2.6.3 TH+ fibre density measurements  
Due to problems with brain sectioning, one further 6-OHDA rat was excluded from TH+ fibre 
density measurements (no cortex) leaving nine 6-OHDA rats and twelve sham rats. Analysis of 
DA denervation in cortical regions (somatosensory cortex, motor cortex, cingulate cortex) 
was conducted on the TH stained sections. 60 digital images (ten contralateral, ten ipsilateral 
per section; three consecutive sections) of each rat for each of the three aforementioned 
brain regions were captured at 40x magnification using a computerized image analysis set-up 
(Zeiss Axioscope, Carl Zeiss, Gottingen, Germany). Individual fibres in each micrograph were 
automatically detected using the threshold option triangle in ImageJ (v1.50b; 
http://imagej.nih.gov/ij/, U.S. National Institutes of Health, Bethesda, Maryland, USA). Briefly, 
RGB micrographs were converted to BW 8-bit images, and then subjected to background 
subtraction for bias correction. Then, bias corrected images were thresholded to only 
highlight the TH+ fibres and the area fraction was determined. The area fraction is the 
percentage of pixels in the image that have been highlighted after applying ImageJ’s triangle 
threshold. The TH+ fibre density is therefore expressed as this area fraction. 
 
2.6.4 Optical fractionator cell counts of TH-positive neurons in the SN 
To examine the total number of TH-positive (TH+) neurons in the SN, stereological 
quantification was performed using the optical fractionator probe in Stereo investigator 
software (v7.0, MBF Bioscience, Chicago, IL, USA) running on a computerized image analysis 
set-up (Carl Zeiss). This procedure was conducted in ten 6-OHDA and twelve sham rats. TH+ 
cell counts in the SN were determined in both groups for each hemisphere separately. Every 
12th 30 μm section encompassing the full rostrocaudal extent of the SN was systematically 
sampled using an unbiased counting frame. This resulted in an average of 3-5 sections being 
selected for the SN. The SN was manually outlined at ×2.5 magnification and counting frames 
were systematically distributed with known x and y steps throughout the region from a 
random starting point. Cross sectional area of the counting frame was set to 150x150 μm2 
and superimposed on the field of view by the software. This frame area generated on 
average 4-6 discrete counts per frame. The sampling grid area was estimated individually for 
each animal in such a way that it comprises of approximately 15-20 counting frames per 
section. A guard zone of 0.5 μm thickness was used at the top and bottom of each section 
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with an optical dissector height of 14 μm. All cell counts were performed under ×40 
magnification. The estimates of the total number of TH+ cells in the SN were calculated 
according to the optical fractionator equation (West, 1999). The coefficients of error were 
calculated according to Gundersen and colleagues with values <0.10 accepted (Gundersen 
and Jensen, 1987).  
 
Statistical analysis 
All data are expressed as mean ± standard error of the mean (SEM) unless stated otherwise. 
MRI based voxel-wise image analysis was performed using MATLAB, SPM and FSL. Voxel-wise 
non-parametric permutation (N=5000 permutations) inference employing FSL tool 
Randomise and the threshold-free cluster enhancement method as described elsewhere 
(Smith and Nichols, 2009, Winkler et al., 2014) were used to compare the composite volume 
maps (GMV and WMV) group differences in 6-OHDA and sham rats. Generally, a non-
parametric approach is recommended for studies with a low degree of freedom (~20) 
(Nichols and Holmes, 2002). For an unpaired two-sample t-test the following formula applies 
to calculate the degree of freedom in our experiment:  
𝑛1 + 𝑛2 − 2 = 𝑑𝑒𝑔𝑟𝑒𝑒𝑠 𝑜𝑓 𝑓𝑟𝑒𝑒𝑑𝑜𝑚 
where n1 is the number of subjects in group one and n2 is the number of subjects in group 
two. In this chapter, the group pairing resulted in 22 degrees of freedom. Voxels with a 
probability value below 0.2 in the corresponding priors were excluded to include only voxels 
with sufficient grey or white matter proportion (May et al., 2007). This diminishes possible 
edge effects between grey matter, white matter or CSF. A voxel was considered significant 
only if it exceeded the statistical threshold (q<0.05), whereby correction for multiple 
comparison was done by using the family-wise error rate (FWER). Statistical analysis of the 
differences in TH+ cells and fibres were conducted using Graphpad Prism (v5.00; GraphPad 
Software, La Jolla, CA, USA, www.graphpad.com). A two-way ANOVA with Bonferroni post 
hoc analysis was conducted on the absolute number of TH+ nigral neurons with group as 
between-subjects factor and hemisphere as within-subjects factor. The TH+ fibre density in 
cortical parts of the brain was compared using two-way ANOVA (Bonferroni post hoc) with 
group and hemisphere as main factors. TH+ fibre density were shown as percent of the pixel 
area fraction and expressed as mean ± SEM. Correlations between the mean grey matter 
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probability values inside the S1, M1, C1 and SN ROI, and histology or behaviour (6-OHDA 
group only), respectively, were evaluated using a paired Pearson’s correlation. Statistical 
significance in this chapter was assumed at p<0.05, unless stated otherwise.   
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Results 
Behavioural testing: Apomorphine-induced rotations 
Following apomorphine challenge, sham rats (N=12) showed a negligible amount of net 
contralateral turns, whereas 6-OHDA rats (N=13) displayed on average 215.8 ± 42.4 
(mean±SD) contralateral turns. Three 6-OHDA-lesioned rats did not reach the cut-off of at 
least 100 net contraversive rotations and were thus excluded from further experiments.  
 
Voxel-based morphometry reveals grey matter volume decreases in cortical and subcortical 
brain regions in 6-OHDA-lesioned rat 
We next sought to determine whether unilateral lesioning of the MFB leads to MRI 
detectable grey and white matter volume (GMV and WMV, respectively) changes. Figure 3 
shows coronal brain slices of the population specific template (PST) highlighting voxels where 
GMV differed significantly (q=0.05; FWER-corrected) in 6-OHDA rats compared to shams. The 
principle findings are that large clusters of significant GMV decrease were found bilaterally in 
amygdala, cingulate cortex, motor cortex and somatosensory cortex. Additionally, significant 
voxels of GMV decrease were found in the entorhinal cortex, temporal cortex, dorsal 
striatum, hippocampus, SN and thalamus of the ipsilateral (lesioned) hemisphere. To 
precisely localize these GMV changes an atlas-based approach was employed. See Table 1 for 
a summary of the30 ROIs containing the most significant voxels. The main finding was that 
brain regions containing the most significant voxels of reduced GMV (q<0.05, FWER 
corrected) were primarily located in the ipsilateral hemisphere of the 6-OHDA lesioned 
animals, notably in the cortex. There were no significant clusters of increased GMV in 6-
OHDA-lesioned animals compared to sham controls. 
Significant clusters of WMV loss were also present in the ipsilateral thalamus, a structure that 
is primarily composed of grey matter but classified as WMV for the purpose of VBM analysis. 
No other changes in the WMV maps were observed.  
 
Figure 3 
Table 1 
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Post-mortem examination confirms cortical dopaminergic denervation  
Qualitative inspection of the immunohistological profile of TH in 6-OHDA rats revealed an 
almost complete loss of TH+ neurons in the SN (Figure 4A), which is associated with a marked 
striatal dopaminergic denervation (Figure 4B). To quantitatively determine the extent of the 
nigral degeneration, we counted the number of TH+ neurons in the SN in both groups. Table 
2 shows the neuronal counts in sham and 6-OHDA rats. Two-way ANOVA of TH+ cell counts 
revealed a main effect of group: F(1,40)=10.52, p=0.0024; hemisphere: F(1,40)=38.95, 
p<0.0001 and group x hemisphere interaction: F(1,40)=18.21, p=0.0001). Post hoc Bonferroni 
analysis confirmed a significant (p<0.0001) reduction in TH+ cells in the ipsilateral substantia 
nigra of 6-OHDA rats (615.30±114.91) compared to sham operated rats. 
 
Figure 4 
Table 2 
 
Further qualitative examination of the 6-OHDA lesioned rat brains revealed markedly 
reduced dopaminergic innervation in cortical brain areas ipsilateral to the lesion, notably in 
the motor, cingulate and somatosensory cortices (Figure 5). We therefore next sought to 
determine the density of TH+ fibres in the cortex. Density values (expressed as % area 
fraction) of TH+ fibres were significantly different between sham and 6-OHDA animals in the 
ipsilateral (but not contralateral) cingulate, motor and somatosensory cortices, according to 
two-way ANOVA (with the main effect of group: cingulate cortex, F(1,38)=16.23, p=0.0003; 
motor cortex, F(1,38)=15.85, p=0.0003 and somatosensory cortex, F(1,38)=66.77, p<0.0001). 
Bonferroni post hoc analyses showed that cortical TH+ fibre density in 6-OHDA rats was 
significantly (p<0.0001) reduced in the cingulate, motor and somatosensory cortices (Table 
3). 
 
Figure 5 
Table 3 
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To investigate the relationship between grey matter volume changes and TH+ 
immunoreactivity in these cortical regions, mean grey matter probability values inside the S1, 
M1 and C1 ROI were correlated with the density of TH+ fibres in 6-OHDA and sham-operated 
rats (Table 4). There were no significant correlations between the density of TH+ fibres and 
the mean grey matter probability inside the S1, M1 and C1, or between the TH+ neurons and 
the mean grey matter probability values in the lesioned SN (Table 4). We also examined and 
did not detect any significant correlations between the rotational behaviour after 
apomorphine injection and the mean grey matter probability values inside the S1, M1, C1 
and S2 in 6-OHDA rats (Table 5). 
 
Table 4 
Table 5 
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Discussion 
The principle findings of this study are that VBM analysis detected specific patterns of 
significant GMV decreases in several subcortical regions of the ipsilateral (lesioned) 
hemisphere, including the site of the primary lesion following 6-OHDA lesioning. This pattern 
of GMV decreases extended to several cortical areas of the cortex, bilaterally in both 
hemispheres. No significant GMV increases were noted. Focusing on the cortex, we observed 
that the sites of GMV decrease also showed a marked denervation of the dopaminergic (TH 
positive) fibres, but these did not correlate with the observed volume changes in these 
regions.  
 
Structural alterations in the 6-OHDA rat are both similar and distinct to other neurotoxin 
models of Parkinsonism 
Several prior structural MRI have been conducted on 6-OHDA lesioned rats (Van Camp et al., 
2009, Van Camp et al., 2010, Soria et al., 2011, Florio et al., 2013), although none tested for 
the presence of widespread structural changes utilising a whole brain morphometry method. 
Indeed, prior structural MRI studies in this model have focused on identifying changes in MRI 
parameters (volume, diffusion or relaxation time) within a priori selected ROIs such as the 
substantia nigra or the striatum. Using this approach, Florio et al. (2013) reported shrinkage 
of the ipsilateral hemisphere in 6-OHDA rats, which is in agreement with our observation of 
GMV decrease in several brain regions within the ipsilateral hemisphere. In addition, bilateral 
trend-level changes in diffusion weighted imaging data are reported in the cortex of 6-OHDA 
lesioned rats (Soria et al., 2011) echoing the bilateral GMV changes in the motor and 
cingulate cortices observed in our study.  
Prior studies have utilised a similar, but subtly different automated morphometry method 
(deformation-based morphometry) for whole brain MR image analysis in a proteasome 
inhibitor (lactacystin) lesioned rat model of PD (Vernon et al., 2010, Vernon et al., 2011). 
Here, the lactacystin is infused into the left-MFB, leading to widespread brain pathology. 
Despite some important differences between the neurotoxic mechanisms in the two models, 
there is a striking overlap in the MR imaging findings. In particular, lactacystin rats show 
cortical, striatal and thalamic GMV atrophy in the lesioned hemisphere (Vernon et al., 2011, 
Harrison et al., 2015), all of which were also detected in the 6-OHDA rats. Of note is that the 
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clusters of cortical changes were also extending into the contralateral (non-lesioned) 
hemisphere. In contrast, prior studies in the lactacystin-lesioned rat did not find significant 
volume changes in the hippocampus, perhaps due to the small sample size compared to the 
current study (Vernon et al., 2010, Vernon et al., 2011). Furthermore, by three weeks post-
lesion lactacystin also induced visible deformation of the ventral midbrain, extending beyond 
the substantia nigra, which worsened with increasing time post-lesion and was due to 
extensive neuronal loss (Vernon et al., 2011, Harrison et al., 2015, Pienaar et al., 2015). In the 
current study, 6-OHDA lesioned rats did display significant GMV atrophy in the hippocampus 
and did not show extensive GMV atrophy in the midbrain, but rather, restricted nigral 
atrophy. It should also be noted that we were not able to also confirm ventricular 
enlargement in the 6-OHDA rat, which could be explained by the limitation of VBM which 
only uses grey and white matter segments for the analysis. Since only a single-time point was 
examined in the current study, we cannot exclude the possibility that such changes would 
emerge in the 6-OHDA model at longer time-points post-lesion. Nevertheless, these data 
suggest some important commonalities but also differences in the two model systems, which 
may be expected given the potential for non-selective toxicity with lactasystin lesions, 
particularly at higher doses (Vernon et al., 2011, Mackey et al., 2013). Importantly, features 
such as midbrain atrophy are more characteristic clinically of atypical Parkinsonism such as 
progressive supranuclear palsy and multiple system atrophy (Paviour et al., 2006). It may 
therefore be suggested that high-dose lactacystin lesion models have greater face validity to 
atypical forms of Parkinsonism. Further longitudinal studies directly comparing the two 
models using lower doses of lactacystin that induce more selective lesions may however be 
informative in this respect (Mackey et al., 2013).  
 
Comparison to clinical findings 
Interestingly, many of the brain regions we found to have decreased GMV in the 6-OHDA rats 
correspond to the analogous brain regions affected by PD in humans, according to a recent 
voxelwise meta-analysis of clinical VBM studies (Shao et al., 2015). In particular, atrophy of 
the prefrontal, temporal, occipital and parietal cortices can be generally observed even in 
early stage PD (Borghammer et al., 2010, Lyoo et al., 2010, Tessa et al., 2014), but is more 
pronounced in advanced PD, specifically in the temporal brain areas of PD patients with 
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dementia (Burton et al., 2004, Song et al., 2011, Weintraub et al., 2011, Hattori et al., 2012, 
Melzer et al., 2012). As can be appreciated from these studies, cortical atrophy has become a 
defining feature of both idiopathic PD and PD with dementia, and here we supply evidence of 
the similar MRI phenotype in the 6-OHDA rat model.  
 
Structure-function relationships 
Our preclinical data confirm the clinical findings and earlier pre-clinical data from other 
models (e.g. (Vernon et al., 2011)), which suggest that cortical GMV decrease is a prominent 
consequence of the nigrostriatal degeneration. This notion is strengthened by the evidence 
of cortical functional changes following 6-OHDA lesioning. Specifically, using positron 
emission tomography imaging (Casteels et al., 2008) and 2-deoxy-D-glucose autoradiography 
(Carlson et al., 1999) researchers have revealed a decreased glucose metabolism in the 
sensorimotor cortex, and by electroencephalography Sharott and colleagues have observed 
reduced neural firing also in the sensorimotor cortex (Sharott et al., 2005). It is however not 
clear whether the decreased metabolism and neural firing are causes or consequences of the 
reduced volume of cortical grey matter. 
Of interest is a previous study that demonstrated a positive correlation between diminished 
cerebral blood volume response to a nociceptive stimulus and dopaminergic denervation in 
the striatum in 6-OHDA rats (Chen et al., 2013). Although speculative, it is conceivable that 
cortical dopaminergic denervation may affect cerebral blood volume response in the cortex 
in a similar fashion, which may be further followed-up using resting-state functional MRI to 
establish a structure-function relationship. 
It was beyond the scope of this project to perform extensive behavioural measurements 
which have already been well characterised by others (Schwarting and Huston, 1996, 
Deumens et al., 2002). Thus, we were not able to directly explore the association between 
MRI-derived structural changes and parkinsonian behavioural deficits. Historically, 6-OHDA 
lesion was deemed to be restricted to the nigrostriatal system and therefore the most 
frequently conducted behavioural tests are for motor activity and coordination, which have 
indeed shown a good correlation between the nigrostriatal degeneration and motor defects 
in tasks such as accelerating rotarod (Monville et al., 2006, Carvalho et al., 2013) and 
adjusting stepping test (Olsson et al., 1995, Decressac et al., 2012). 
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In light of our cortical atrophy findings, however, it would be of future interest to determine 
the relative contribution of the cortical vs. subcortical structural changes to the different 
aspects of motor and cognitive behavioural deficits in this model. It may be hypothesised that 
cortical damage additionally contributes to both motor as well as sensory deficits in the 6-
OHDA rat. It has been shown, for example, by Montoya and colleagues that a unilateral lesion 
of the rat sensorimotor cortex leads to a clear motor impairment (Montoya et al., 1991) 
underscoring the contribution of the cortex to movement. Moreover, another study showed 
specific memory and learning deficits in 6-OHDA rats (Dolatshahi et al., 2015), which are in 
line with the widespread GMV loss we observed in the prefrontal cortex, a region important 
for cognitive function that is also known to be affected in human PD patients. Additionally, 
the aforementioned lactacystin rat study found that the thinning of the motor cortex, rather 
than nigrostriatal changes, best predicted the degree of motor deficits (Vernon et al., 2011). 
The degree to which cortical changes influence cognitive (dys)function in 6-OHDA rat remains 
to be confirmed given that several other studies did not find any evidence of reduced 
cognitive abilities in this model (Mura and Feldon, 2003, Carvalho et al., 2013). 
 
The neurobiological correlate of grey matter changes is diverse 
The interpretation of the VBM results as tissue volume changes are based on significant 
differences in MRI contrast, which can also be governed by the changes in tissue properties. 
For example, a recent VBM study in rodents reported a significant correlation of VBM signal 
with changes in spine density (Keifer et al., 2015), and another VBM study in a rat model of 
multiple sclerosis found evidence for changes in dendrite morphology in the sensorimotor 
cortex alongside GM atrophy (Tambalo et al., 2015). Similarly, in a rat model of 
schizophrenia, MRI-derived GM atrophy was suggested to be associated with gross neuronal 
loss and dendrite plasticity (Wu et al., 2016) highlighting the effect of microscale changes on 
macroscopic morphology. 
We speculate that both gross neuronal loss in the substantia nigra and the ensuing 
dopaminergic denervation contributed to MRI-derived GM atrophy in 6-OHDA rats. In 
particular, we showed a remarkable overlap of GMV loss in cingulate, motor and 
somatosensory cortex on the lesioned side with a significant TH+ fibre denervation in the 
same areas in 6-OHDA rats. TH is a marker of catecholamine neurons, which include DA and 
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noradrenergic neurons. Two previous 6-OHDA studies, in which noradrenergic neurons were 
protected by desipramine prior to the lesioning surgery showed a similar cortical denervation 
of TH+ fibres (Debeir et al., 2005, Ueno et al., 2014) suggesting that the loss of TH+ fibres in 
the cortex is DA-specific.  
Furthermore, as expected after 6-OHDA MFB lesioning, we found a significantly reduced 
number of dopaminergic neurons in the lesioned SN and the marked DA denervation of the 
striatum. Notably, both grey matter loss in the SN and the striatum were successfully 
detected using VBM analysis, too. Our histopathological examinations of the cortex are 
supported by, and extend previous reports of DA fibre loss in the ipsi-lesional cingulate and 
motor cortices in the 6-OHDA rats (Debeir et al., 2005, Castillo-Gomez et al., 2008, Hou et al., 
2010, Ueno et al., 2014).  
We speculate that the loss of DA fibres in the cortex and elsewhere indirectly underlies 
changes observed by MRI. MRI measurements are particularly sensitive to changes in water 
proton properties, which can be driven by diverse cellular and extracellular processes 
(Zatorre et al., 2012, Sumiyoshi et al., 2014) such as neurogenesis, synaptogenesis, changes 
in neuronal and glial morphology as well as extracellular space and inflammation (Eriksson et 
al., 2009, Lerch et al., 2011, Finlay et al., 2014). With respect to this, DA denervation in the 
cortex and striatum has been shown to lead to a structural remodelling of the surrounding 
tissue such as altered wiring of intrinsic inhibitory GABA-ergic circuits (Solis et al., 2007, 
Castillo-Gomez et al., 2008), reduced synaptic density (Castillo-Gomez et al., 2008, Hou et al., 
2010), spine enlargement (Ueno et al., 2014) and loss of glutamatergic input from the 
prefrontal cortex to the medium spiny neurons of the striatum (Day et al., 2006, Solis et al., 
2007), all of which are likely to contribute to changes in the water proton properties 
ultimately modulating MRI signal. Given the lack of correlation between MRI and histological 
measures, it is likely that the dopaminergic denervation triggers a cascade of events that 
eventually lead to microscale tissue reorganization, which then ultimately underlie the 
observed MRI signal changes. 
Bilateral brain changes are a distinctive feature of the unilateral 6-OHDA rat model 
It is of note that we found widespread changes in both sides of the brain in this unilaterally 
lesioned rat model. This supports previous findings reporting bilateral structural, 
physiological and functional changes in the 6-OHDA rat brain (Morgan and Huston, 1990, 
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Pelled et al., 2002, Breit et al., 2008, Pierucci et al., 2009, Van Camp et al., 2010, Soria et al., 
2011, Viaro et al., 2011). For example, Pelled and colleagues described a bilateral 
overactivation of the somatosensory cortex after a unilateral electrical forepaw stimulation 
(Pelled et al., 2002). Another study reported bilateral changes in water diffusion properties as 
measured by diffusion-weighted imaging in the SN and the cortex (Soria et al., 2011). Using 
intracortical microstimulation, Viaro et al. reported bilaterally reduced M1 excitability (Viaro 
et al., 2011). Together with our findings, these results suggest that the mutual influence of 
both hemispheres in the pathophysiology of the unilateral 6-OHDA rat is an important and 
defining feature of this model. 
 
Utility of VBM in 6-OHDA rats 
The rationale for using VBM in this study was to define an MRI phenotype based on a 
technique that is now widely used in clinical research. Given the paucity of analogous studies 
in 6-OHDA rats, our present work establishes the first MRI phenotype based on VBM image 
analysis and therefore helps to bridge the gap between clinical and preclinical studies. 
Although further work is required to elucidate the mechanisms that underlie the cortical grey 
matter loss in this rat model, the MFB 6-OHDA rat model might be useful for studying the 
controversial effect of DA replacement therapies in humans (Finlay et al., 2014). Indeed, 
previous reports have found evidence of modulating effects of levodopa therapy on both the 
cortical MRI signal in healthy subjects (Salgado-Pineda et al., 2006) and in dyskinetic PD 
patients (Cerasa et al., 2013) and the 6-OHDA rats model may be a suitable model to 
investigate the relationship between cortical brain changes and levodopa treatment.  
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Conclusion 
We have shown that VBM can be readily applied to rats for morphometric assessment of 6-
OHDA lesion induced changes. We found VBM particularly useful to localize the large clusters 
of grey matter loss in the cortex, which matched the areas of DA fibre loss. This shows the 
potential of automated image analysis to advance the current preclinical MRI research by 
revealing new and unexpected sites of neurodegeneration beyond the primary lesioned 
pathway. Additionally, the changes were similar to those described in other rat models and in 
the human advanced PD, reinforcing not only the value of the MFB 6-OHDA rat model as a 
model of late-stage PD, but also opening up avenues toward utilising GMV in animals as 
proxy marker of (neuro)degeneration in humans. These data thus reinforce the power and 
utility of combining MRI and clinically relevant imaging analysis tools for the evaluation of 
rodent models of Parkinsonism. We therefore propose that this established framework 
should be applied as standard to emerging PD rat models that show slower and progressive 
neurodegeneration such as the recombinant adeno-associated viral vector overexpressing 
alpha-synuclein rat (Decressac et al., 2012, Van der Perren et al., 2014) and transgenic mouse 
models (Janezic et al., 2013), which ultimately have greater construct and face validity. For 
example, this would facilitate the correlation of morphological phenotypes with the onset of 
behavioural deficits in a longitudinal fashion, which may ultimately increase the chance of 
identifying predictive biomarkers for early-onset PD, response to therapy and disease 
progression and establish at the cellular level the mechanisms which drive MRI signal changes 
in PD patients. 
  
25 
 
Conflict of interest statement 
None of the material contained in this manuscript has been published or presented 
previously, except in abstract form at international conferences. This paper has not been 
submitted for publication elsewhere, and it has been reviewed and approved by all the 
authors. There are no financial or other relationships that could lead to a conflict of interest. 
 
Acknowledgements 
This study was kindly supported by the Lily Safra Hope Foundation, which was not involved in 
the preparation of the article. 
 
26 
 
Figures and Tables Legend 
 
FIG1 
Tissue probability maps for (A) grey matter, (C) white matter and (D) CSF in the living rat 
brain. 
 
FIG2 
Rat brain parcellation scheme. Rat brain was segmented into 154 ROIs (77 on each 
hemisphere). Each bilateral ROI is labelled differently and overlaid onto coronal slices of the 
rat brain template. 
 
FIG3 
Voxel-wise differences in local grey matter between the 6-OHDA and sham group three 
weeks post-lesioning. Absolute regional grey and white matter volume maps were computed 
and non-parametric permutation two-sample t-test was applied at every voxel to identify 
significant grey and white matter volume changes. Statistical parameter maps were overlaid 
on the population-specific template as anatomical reference. The colour calibration bar 
represents the q-values with a threshold level of q<0.05 (FWER corrected). Increased regional 
volume in 6-OHDA rats compared to shams was not observed, decreased regional volume is 
displayed in blue. Note, no true white matter changes were observed. L, lesioned side; R, 
unlesioned side. 6-OHDA rats N=13; sham rats N=11. 
 
FIG4 
Pattern of TH immunoreactivity in a representative 6-OHDA rat. DAB immunolabelling 
showing the location of TH+ neurons in the contralateral SN (A) and fibres in the contralateral 
striatum (B) but not ipsilateral, as indicated by the asterisks. L, ipsilateral, lesioned side; R, 
contralateral, unlesioned side. 
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FIG5 
Tyrosine hydroxylase immunoreactivity in sections through prefrontal and frontal cortex from 
a representative 6-OHDA rat. (A) Primary motor cortex and the magnified areas in the (D) 
contralateral and (E) ipsilateral hemisphere. (B) Cingulate cortex and the magnified areas in 
the (F) contralateral and (G) ipsilateral hemisphere. (C) Somatosensory cortex and the 
magnified areas in the (H) contralateral and (I) ipsilateral hemisphere. Overall, the ipsilateral 
cortex was found to have a profound loss of TH+ fibres, which was associated with 
dopaminergic striatal denervation as evidenced by the absence of TH+ immunoreactivity in 
the ipsilateral striatum. White frames indicate the areas with higher magnification (x40). 
Scale bar = 100 μm in I (applies to D-I). L, ipsilateral, lesioned side; R, contralateral, 
unlesioned side. 
 
TAB1 
Results of the ROI-based localization analysis of the 30 ROIs containing the most significant 
voxels of regional grey matter volume decrease three weeks after 6-OHDA lesioning. 
Arranged in descending order from lowest to highest q-value found in each brain region. 
Voxels thresholded at q<0.05, FWER corrected. L, ipsilateral 6-OHDA lesioned hemisphere; R, 
contralateral unlesioned hemisphere. H, hemisphere; T, total number of voxels within the 
brain region; S, total number of significant voxels within each brain region; S/T, percentage of 
voxels that are significant within the brain region; Q, smallest q-value of a voxel found inside 
a ROI. 
 
TAB2 
Stereological estimates of nigral TH+ neuronal numbers in sham and 6-OHDA rats. Neuronal 
counts of TH+ cells were significantly different between sham and 6-OHDA animals as two-
way ANOVA revealed with main effect of group: F(1,40)=10.52, p=0.0024; main effect of 
hemisphere: F(1,40)=38.95, p<0.0001 and group/hemisphere interaction: F(1,40)=18.21, 
p=0.0001 (Bonferroni post hoc test 6-OHDA ipsilateral vs. sham ipsilateral ****p<0.0001). 
Data are expressed as mean cell count ± SEM. 6-OHDA rats N=10; sham rats N=12.  
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TAB3 
Comparison of TH immunoreactivity of cortical dopaminergic fibres in 6-OHDA and sham rats. 
TH+ fibre density was significantly different between sham and 6-OHDA animals in the 
ipsilateral but not contralateral hemisphere as two-way ANOVA revealed with main effect of 
group: cingulate cortex, F(1,38)=16.23, p=0.0003; motor cortex, F(1,38)=15.85, p=0.0003; 
somatosensory cortex, F(1,38)=66.77, p<0.0001. (Bonferroni post hoc test revealed 
significantly reduced TH+ fibre density in ipsilateral cingulate, motor and somatosensory 
cortices in 6-OHDA rats compared to shams, ****p<0.0001). Data are shown as percent of 
the area fraction of TH+ fibre pixels and expressed as mean ± SEM. 6-OHDA rats N=9; sham 
rats N=12. CC, cingulate cortex; MC, motor cortex; SC, somatosensory cortex. 
 
TAB4 
Correlation of the immunohistological profile of TH and grey matter volume changes in four 
regions of interest. Correlation analyses were done using the Pearson’s correlation 
coefficient. No significant correlation was found. Numbers in brackets indicate the 
correlation coefficient for sham rats. TH, tyrosine hydroxylase; GMV, grey matter volume; C1, 
primary cingulate cortex; M1, primary motor cortex; S1, primary somatosensory cortex; SN, 
substantia nigra. 6-OHDA rats N=9, sham rats N=11. 
 
TAB5 
Correlation of apomorphine-induced rotations the immunohistological profile of TH and grey 
matter volume changes in four regions of interest. Correlation analyses were done using the 
Pearson’s correlation coefficient. No significant correlation was found. GMV, grey matter 
volume; C1, primary cingulate cortex; M1, primary motor cortex; S1, primary somatosensory 
cortex; SN, substantia nigra. 6-OHDA rats N=9. 
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